Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 8-K Material Event for the period ending Friday, August 7, 2020

Acro Biomedical Co., Ltd.

HISTORY TOOLS
CIK: 1622996 Ticker: ACBM

View differences made from one to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: 2020 Long-Term Incentive Plan
Ticker: ACBM
CIK: 1622996
Form Type: 8-K Corporate News
Accession Number: 0001640334-20-002068
Submitted to the SEC: Thu Aug 13 2020 6:04:26 AM EST
Accepted by the SEC: Thu Aug 13 2020
Period: Friday, August 7, 2020
Industry: Amusement And Recreation Services
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Vote of Security Holders

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/acbm/0001640334-20-002068.htm